# OnCo record idea-menin-infant-all (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-menin-infant-all/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-menin-infant-all" ;
  schema:name "Menin inhibitors for infant KMT2A-rearranged ALL"@en ;
  schema:description "Infant leukaemia is driven almost entirely by KMT2A fusions, which menin inhibitors were built to attack. Add them to the new blinatumomab-containing backbone."@en ;
  schema:url <https://onco.cc/ideas/idea-menin-infant-all/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41586-023-05812-3> ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/all-infant/> ;
  onco:targets <https://onco.cc/targets/kmt2a/>, <https://onco.cc/targets/menin/> ;
  onco:drugs <https://onco.cc/drugs/revumenib/>, <https://onco.cc/drugs/ziftomenib/>, <https://onco.cc/drugs/blinatumomab/> ;
  onco:trials <https://onco.cc/trials/interfant-06/>, <https://onco.cc/trials/augment-101/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-blinatumomab-all-leukemia-n-engl-j-med-2017/>, <https://onco.cc/key-papers/paper-blinatumomab-all-leukemia-lancet-oncol-2015/>, <https://onco.cc/key-papers/paper-blinatumomab-all-leukemia-j-clin-oncol-2011/> .